查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1617163

中央靜脈導管市場至2030年的預測：按產品、特性、設計、成分、最終用戶和地區的全球分析

Central Venous Catheter Market Forecasts to 2030 - Global Analysis By Product (Tunneled Catheters and Non-Tunneled Catheters), Property, Design, Composition, End User and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 200+ Pages | 商品交期: 2-3個工作天內

價格

根據 Stratistics MRC 的資料，2024年全球中央靜脈導管市場規模為 28.61億美元，預計到2030年將達到 46.935億美元，預測期內年複合成長率為 8.6%。中央靜脈導管（CVC）是一種插入頸部、胸部或鼠蹊部大靜脈的醫療設備，用於輸送藥物、液體、營養物質或採集血液樣本。 CVC 通常用於重症患者或接受化療或透析等長期治療的患者。 CVC 專為長期進入中心靜脈系統而設計，是周邊靜脈管線的安全替代方案。其使用有感染疾病、血栓症等風險，需謹慎管理。

據世界衛生組織（WHO）表示，每年約有 3000萬人被診斷患有敗血症。

慢性病增加

越來越多的癌症、心血管疾病和腎臟疾病等慢性疾病往往需要化療、透析、靜脈輸液等長期治療，而CVC則扮演重要角色。隨著世界人口的增加，這些慢性疾病的盛行率也增加，進一步推動了需求。此外，CVC 技術的進步提供了更高的安全性和效率，也有助於其採用率的提高。醫療保健系統越來越關注重症加護，並進一步加速 CVC 的使用。患者數量的增加以及對專業醫療護理的需求推動市場的成長。

感染和併發症的風險

感染疾病和併發症（例如導管相關血流感染疾病（CRBSI）和血栓症）的風險會導致住院時間延長、醫療費用增加以及患者發病率增加。因此，醫療保健提供者在使用 CVC 時可能會持謹慎態度，這可能會限制其採用。此外，嚴格的感染控制規定和專門培訓的需要使 CVC 的實施更加複雜。因安全問題而召回的產品也對市場信心產生負面影響。儘管在抗感染設計方面取得了創新，這些風險仍然是一個主要障礙。

產品創新

抗菌塗層等產品創新有助於降低感染風險，並解決與使用 CVC 相關的主要問題之一。此外，更耐用、更易於使用的導管的開發改善患者的治療效果和醫療服務提供者的滿意度。導管材料的進步提高了靈活性和生物相容性，也有助於長期使用。這些創新不僅推動了市場成長，而且還促進了重症加護環境中對安全有效的醫療設備的需求不斷成長。因此，醫療保健提供者將發現更容易採用新技術，進一步擴大市場。

成本和醫療保健預算限制

CVC 設備及其插入程序相關的高成本限制了其採用，特別是在資源匱乏的環境中。醫院預算限制可能會優先考慮基本治療，並減少對 CVC 等先進醫療設備的撥款。此外，醫院可能會選擇更便宜的替代方案，這可能會影響患者照護的品質。對具有成本效益的解決方案和資源最佳化的需求不斷成長，給 CVC 市場帶來了壓力。購買高品質的導管可能很困難，尤其是對於新興市場的醫院而言。這可能會推遲更新、更有效的CVC 技術的採用。

COVID-19 的影響

COVID-19 大流行中央靜脈導管（CVC）市場產生了重大影響，導致供應鏈中斷、選擇性手術延遲以及醫療重點轉向 COVID-19 治療。這減少了對非緊急醫療程序的需求，並影響了 CVC 在醫院的使用。然而，疫情增加了重症患者對重症監護和長期照護的需求，創造了對 CVC 的需求。隨著醫療保健系統在大流行後適應，市場復甦，並重新關注安全和感染預防。

抗菌導管領域預計將成為預測期內最大的市場

由於與傳統導管相關的感染風險不斷增加，抗菌導管區隔預計將出現良好的成長。這些專用導管塗有抗菌劑，減少了感染的機會，這是醫療保健提供者主要關心的問題。隨著醫院尋求提高病患安全，對抗菌 CVC 的需求不斷增加。此外，這些導管透過減少醫療相關感染來改善患者的治療效果，最終降低治療成本。抗菌塗料的技術進步進一步推動了市場的成長。

專科診所產業預計在預測期內年複合成長率最高

透過為癌症、心血管疾病和腎臟疾病等慢性疾病提供重點治療，預計專科診所業務在預測期內將實現最高的年複合成長率。這些診所提供化療和透析等量身定做的治療方法，而 CVC 對於長期藥物治療非常重要。此類疾病的日益普及刺激了對專業持續照護的需求，並推動了 CVC 的使用。此外，這些診所通常配備先進的設備和醫療專業知識，確保更安全地使用 CVC。由於患者數量的增加和醫療基礎設施的改善，專科診所已成為推動市場擴張的關鍵領域。隨著更多專科診所的出現，尤其是在新興市場，這一趨勢預計將持續下去。

佔有率最大的地區

由於癌症、心血管疾病和腎臟疾病等慢性病盛行率上升，預計亞太地區在預測期內將佔據最大的市場佔有率。在中國、印度和日本等國家，專科診所和醫療機構數量的增加以及重症加護治療機會的改善進一步增加了對 CVC 的需求。此外，醫療基礎設施的改善和先進醫療意識的提高推動市場擴張。因此，亞太地區預計將在未來幾年為全球 CVC 市場的成長做出重大貢獻。

年複合成長率最高的地區：

由於癌症、心血管疾病和腎臟疾病等慢性病的盛行率很高，預計北美在預測期內的年複合成長率最高。北美醫療保健基礎設施的發展以及專科診所和醫院的增加也推動了對 CVC 的需求。此外，降低感染風險和改善病患治療效果的導管設計創新也在推動市場發展。人口老化和化療和透析等長期治療的使用增加進一步推動市場擴張。監管標準和成熟的醫療保健系統預計將維持該成長軌跡。

免費客製化服務

訂閱此報告的客戶可以存取以下免費自訂選項之1：

  • 公司簡介
    • 其他市場公司的綜合分析（最多3家公司）
    • 主要企業SWOT分析（最多3家公司）
  • 區域細分
    • 根據客戶興趣對主要國家的市場估計、預測和年複合成長率（註：基於可行性檢查）
  • 競爭標基準化分析
    • 根據產品系列、地理分佈和策略聯盟對主要企業基準化分析

目錄

第1章 執行摘要

第2章 前言

  • 概述
  • 相關利益者
  • 調查範圍
  • 調查方法
    • 資料探勘
    • 資料分析
    • 資料檢驗
    • 研究途徑
  • 研究資訊來源
    • 主要研究資訊來源
    • 二次研究資訊來源
    • 先決條件

第3章 市場趨勢分析

  • 促進因素
  • 抑制因素
  • 機會
  • 威脅
  • 產品分析
  • 最終用戶分析
  • 新興市場
  • COVID-19 的影響

第4章 波特五力分析

  • 供應商的議價能力
  • 買方議價能力
  • 替代品的威脅
  • 新進入者的威脅
  • 競爭公司之間的敵對關係

第5章 全球中央靜脈導管市場：依產品

  • 隧道導管
  • 非隧道導管

第6章 全球中央靜脈導管市場：依特性

  • 抗菌導管
  • 非抗菌導管

第7章 全球中央靜脈導管市場：依設計

  • 單腔
  • 雙腔
  • 多腔

第8章 全球中央靜脈導管市場：依構成

  • 聚氨酯
  • 聚四氟乙烯
  • 矽橡膠
  • 其他作品

第9章 全球中央靜脈導管市場：依最終使用者分類

  • 醫院
  • 門診手術中心
  • 專科診所
  • 癌症研究所
  • 其他最終用戶

第10章 全球中央靜脈導管市場：依地區

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 義大利
    • 法國
    • 西班牙
    • 其他歐洲國家
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 紐西蘭
    • 韓國
    • 其他亞太地區
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 南美洲其他地區
  • 中東、非洲
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 卡達
    • 南非
    • 其他中東和非洲

第11章 主要進展

  • 合約、夥伴關係、合作和合資企業
  • 收購和合併
  • 新產品發布
  • 業務拓展
  • 其他關鍵策略

第12章 公司概況

  • ICU Medical, Inc.
  • B. Braun SE
  • Becton, Dickinson and Company
  • Poly Medicure Ltd.
  • Lepu Medical Technology Co., Ltd.
  • Teleflex Incorporated
  • VOGT Medical
  • ZOLL Medical Corporation
  • EETA Surgical
  • QMD
  • Kimal
  • Medtronic
  • Rex Medical, LLC
  • Asahi Kasei Corporation
  • AngioDynamics, Inc.
Product Code: SMRC28042

According to Stratistics MRC, the Global Central Venous Catheter Market is accounted for $2861.0 million in 2024 and is expected to reach $4693.5 million by 2030 growing at a CAGR of 8.6% during the forecast period. A Central Venous Catheter (CVC) is a medical device inserted into a large vein, often in the neck, chest, or groin, to deliver medications, fluids, or nutrients, or to collect blood samples. It is commonly used in critically ill patients or those undergoing prolonged treatments such as chemotherapy or dialysis. CVCs are designed for long-term access to the central venous system, offering a safer alternative to peripheral intravenous lines. Their use carries risks such as infection or thrombosis, requiring careful management.

According to the World Health Organization (WHO) approximately 30 million people are diagnosed every year with sepsis.

Market Dynamics:

Driver:

Rising prevalence of chronic diseases

The rising prevalence of chronic diseases, such as cancer, cardiovascular disorders, and kidney diseases, often require long-term treatment such as chemotherapy, dialysis, or intravenous medicine, where CVCs are crucial. As the global population increases, the incidence of these chronic conditions increases further boosts demand. Additionally, advancements in CVC technology, offering better safety and efficiency, have contributed to their growing adoption. Healthcare systems are focusing more on critical care, further accelerating the use of CVCs. The combination of higher patient volumes and the need for specialized medical care propels market growth.

Restraint:

Risk of infection and complications

The risk of infection and complications, such as catheter-related bloodstream infections (CRBSIs) and thrombosis, can lead to longer hospital stays, increased healthcare costs, and patient morbidity. As a result, healthcare providers are cautious about CVC usage, which may limit their adoption. Moreover, stringent infection control regulations and the need for specialized training further complicate CVC implementation. Product recalls due to safety concerns also negatively affect market confidence. Despite innovations in infection-resistant designs, these risks remain a significant barrier.

Opportunity:

Product innovation

Product innovation such as those with antimicrobial coatings, help reduce infection risks, addressing one of the major concerns associated with CVC use. Additionally, the development of more durable and user-friendly catheters has improved patient outcomes and healthcare provider satisfaction. Advances in catheter materials, making them more flexible and biocompatible, also contribute to longer-term usage. These innovations not only drive market growth but also help meet the increasing demand for safe, effective medical devices in critical care settings. As a result, healthcare providers are more likely to adopt new technologies, further expanding the market.

Threat:

Cost and healthcare budget constraints

High costs associated with CVC devices and their insertion procedures limit their adoption, especially in low-resource settings. Budget constraints in hospitals can lead to prioritization of essential treatments, reducing the allocation for advanced medical devices like CVCs. Additionally; hospitals may opt for cheaper alternatives, potentially compromising patient care quality. The increasing need for cost-efficient solutions and resource optimization adds pressure on the CVC market. Hospitals, particularly in emerging markets, may struggle with the affordability of high-quality catheters. This can slow down the adoption of newer, more effective CVC technologies.

Covid-19 Impact

The COVID-19 pandemic significantly impacted the central venous catheter (CVC) market, leading to supply chain disruptions, delays in elective procedures, and a shift in healthcare priorities toward COVID-19 treatment. This reduced the demand for non-urgent medical procedures, affecting CVC usage in hospitals. However, the pandemic also increased the need for critical care and long-term treatments in severely ill patients, creating demand for CVCs. As the healthcare system adapts post-pandemic, the market is recovering with renewed focus on safety and infection prevention.

The antimicrobial catheters segment is expected to be the largest during the forecast period

The antimicrobial catheters segment is estimated to have a lucrative growth, due to the increasing risk of infections associated with traditional catheters. These specialized catheters are coated with antimicrobial agents that reduce the likelihood of infections, a major concern for healthcare providers. As hospitals aim to enhance patient safety, the demand for antimicrobial CVCs is rising. Additionally, these catheters improve patient outcomes by lowering healthcare-associated infections, which ultimately reduces treatment costs. Technological advancements in antimicrobial coatings further boost market growth.

The specialized clinics segment is expected to have the highest CAGR during the forecast period

The specialized clinics segment is anticipated to witness the highest CAGR growth during the forecast period, by offering focused care for chronic conditions like cancer, cardiovascular diseases, and kidney disorders. These clinics provide tailored treatments, including chemotherapy and dialysis, where CVCs are essential for long-term medication administration. The increased prevalence of such conditions fuels the demand for specialized, continuous care, boosting the use of CVCs. Furthermore, these clinics often have advanced facilities and medical expertise, ensuring safer CVC usage. With rising patient numbers and improved healthcare infrastructure, specialized clinics are a key segment propelling market expansion. This trend is expected to continue, particularly as more specialized clinics emerge in emerging markets.

Region with largest share:

Asia Pacific is projected to hold the largest market share during the forecast period driven by the rising prevalence of chronic diseases like cancer, cardiovascular diseases, and kidney disorders. The increasing number of specialized clinics and healthcare facilities in countries such as China, India, and Japan is enhancing access to critical care treatments, further boosting CVC demand. Additionally, improvements in healthcare infrastructure and rising awareness about advanced medical treatments are propelling market expansion. As a result, Asia-Pacific is expected to be a key contributor to the global CVC market's growth in the coming years.

Region with highest CAGR:

North America is projected to have the highest CAGR over the forecast period, owing to the region's high prevalence of chronic diseases like cancer, cardiovascular disorders, and kidney conditions. Advanced healthcare infrastructure and the increasing number of specialized clinics and hospitals in North America also boost demand for CVCs. Additionally, technological innovations in catheter design, which reduce infection risks and improve patient outcomes, are propelling the market. The aging population and the growing number of long-term treatments, such as chemotherapy and dialysis, further support market expansion. Regulatory standards and a well-established healthcare system are expected to sustain this growth trajectory.

Key players in the market

Some of the key players profiled in the Central Venous Catheter Market include ICU Medical, Inc., B. Braun SE, Becton, Dickinson and Company, Poly Medicure Ltd., Lepu Medical Technology Co., Ltd., Teleflex Incorporated, VOGT Medical, ZOLL Medical Corporation, EETA Surgical, QMD, Kimal, Medtronic, Rex Medical, LLC, Asahi Kasei Corporation and AngioDynamics, Inc.

Key Developments:

In November 2024, ICU Medical announced the creation of a joint venture with Otsuka Pharmaceutical Factory, Inc. This collaboration aims to enhance IV solutions manufacturing and innovation in North America.

In June 2024, B. Braun sold its global orthobiologics business, including TETEC AG in Germany and Aesculap Biologics LLC in the U.S., to Octane Medical Group. This transfer included products such as NOVOCART 3D and NOVOCART Inject, which are innovative cartilage repair solutions.

In May 2024, B. Braun introduced the Flexiva TractSeal Mini Fiber in May 2024. This innovative product is designed for minimally invasive laser lithotripsy, ensuring efficiency in urinary stone treatment. It highlights B. Braun's commitment to expanding its minimally invasive medical technologies portfolio.

Products Covered:

  • Tunneled Catheters
  • Non-Tunneled Catheters

Properties Covered:

  • Antimicrobial Catheters
  • Non-Antimicrobial Catheters

Designs Covered:

  • Single Lumen
  • Double Lumen
  • Multiple Lumen

Compositions Covered:

  • Polyurethane
  • Teflon
  • Silicone Rubber
  • Other Compositions

End Users Covered:

  • Hospitals
  • Ambulatory Surgical Centers
  • Specialized Clinics
  • Cancer Research Institutes
  • Other End Users

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2022, 2023, 2024, 2026, and 2030
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Product Analysis
  • 3.7 End User Analysis
  • 3.8 Emerging Markets
  • 3.9 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Central Venous Catheter Market, By Product

  • 5.1 Introduction
  • 5.2 Tunneled Catheters
  • 5.3 Non-Tunneled Catheters

6 Global Central Venous Catheter Market, By Property

  • 6.1 Introduction
  • 6.2 Antimicrobial Catheters
  • 6.3 Non-Antimicrobial Catheters

7 Global Central Venous Catheter Market, By Design

  • 7.1 Introduction
  • 7.2 Single Lumen
  • 7.3 Double Lumen
  • 7.4 Multiple Lumen

8 Global Central Venous Catheter Market, By Composition

  • 8.1 Introduction
  • 8.2 Polyurethane
  • 8.3 Teflon
  • 8.4 Silicone Rubber
  • 8.5 Other Compositions

9 Global Central Venous Catheter Market, By End User

  • 9.1 Introduction
  • 9.2 Hospitals
  • 9.3 Ambulatory Surgical Centers
  • 9.4 Specialized Clinics
  • 9.5 Cancer Research Institutes
  • 9.6 Other End Users

10 Global Central Venous Catheter Market, By Geography

  • 10.1 Introduction
  • 10.2 North America
    • 10.2.1 US
    • 10.2.2 Canada
    • 10.2.3 Mexico
  • 10.3 Europe
    • 10.3.1 Germany
    • 10.3.2 UK
    • 10.3.3 Italy
    • 10.3.4 France
    • 10.3.5 Spain
    • 10.3.6 Rest of Europe
  • 10.4 Asia Pacific
    • 10.4.1 Japan
    • 10.4.2 China
    • 10.4.3 India
    • 10.4.4 Australia
    • 10.4.5 New Zealand
    • 10.4.6 South Korea
    • 10.4.7 Rest of Asia Pacific
  • 10.5 South America
    • 10.5.1 Argentina
    • 10.5.2 Brazil
    • 10.5.3 Chile
    • 10.5.4 Rest of South America
  • 10.6 Middle East & Africa
    • 10.6.1 Saudi Arabia
    • 10.6.2 UAE
    • 10.6.3 Qatar
    • 10.6.4 South Africa
    • 10.6.5 Rest of Middle East & Africa

11 Key Developments

  • 11.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 11.2 Acquisitions & Mergers
  • 11.3 New Product Launch
  • 11.4 Expansions
  • 11.5 Other Key Strategies

12 Company Profiling

  • 12.1 ICU Medical, Inc.
  • 12.2 B. Braun SE
  • 12.3 Becton, Dickinson and Company
  • 12.4 Poly Medicure Ltd.
  • 12.5 Lepu Medical Technology Co., Ltd.
  • 12.6 Teleflex Incorporated
  • 12.7 VOGT Medical
  • 12.8 ZOLL Medical Corporation
  • 12.9 EETA Surgical
  • 12.10 QMD
  • 12.11 Kimal
  • 12.12 Medtronic
  • 12.12 Rex Medical, LLC
  • 12.14 Asahi Kasei Corporation
  • 12.15 AngioDynamics, Inc.

List of Tables

  • Table 1 Global Central Venous Catheter Market Outlook, By Region (2022-2030) ($MN)
  • Table 2 Global Central Venous Catheter Market Outlook, By Product (2022-2030) ($MN)
  • Table 3 Global Central Venous Catheter Market Outlook, By Tunneled Catheters (2022-2030) ($MN)
  • Table 4 Global Central Venous Catheter Market Outlook, By Non-Tunneled Catheters (2022-2030) ($MN)
  • Table 5 Global Central Venous Catheter Market Outlook, By Property (2022-2030) ($MN)
  • Table 6 Global Central Venous Catheter Market Outlook, By Antimicrobial Catheters (2022-2030) ($MN)
  • Table 7 Global Central Venous Catheter Market Outlook, By Non-Antimicrobial Catheters (2022-2030) ($MN)
  • Table 8 Global Central Venous Catheter Market Outlook, By Design (2022-2030) ($MN)
  • Table 9 Global Central Venous Catheter Market Outlook, By Single Lumen (2022-2030) ($MN)
  • Table 10 Global Central Venous Catheter Market Outlook, By Double Lumen (2022-2030) ($MN)
  • Table 11 Global Central Venous Catheter Market Outlook, By Multiple Lumen (2022-2030) ($MN)
  • Table 12 Global Central Venous Catheter Market Outlook, By Composition (2022-2030) ($MN)
  • Table 13 Global Central Venous Catheter Market Outlook, By Polyurethane (2022-2030) ($MN)
  • Table 14 Global Central Venous Catheter Market Outlook, By Teflon (2022-2030) ($MN)
  • Table 15 Global Central Venous Catheter Market Outlook, By Silicone Rubber (2022-2030) ($MN)
  • Table 16 Global Central Venous Catheter Market Outlook, By Other Compositions (2022-2030) ($MN)
  • Table 17 Global Central Venous Catheter Market Outlook, By End User (2022-2030) ($MN)
  • Table 18 Global Central Venous Catheter Market Outlook, By Hospitals (2022-2030) ($MN)
  • Table 19 Global Central Venous Catheter Market Outlook, By Ambulatory Surgical Centers (2022-2030) ($MN)
  • Table 20 Global Central Venous Catheter Market Outlook, By Specialized Clinics (2022-2030) ($MN)
  • Table 21 Global Central Venous Catheter Market Outlook, By Cancer Research Institutes (2022-2030) ($MN)
  • Table 22 Global Central Venous Catheter Market Outlook, By Other End Users (2022-2030) ($MN)
  • Table 23 North America Central Venous Catheter Market Outlook, By Country (2022-2030) ($MN)
  • Table 24 North America Central Venous Catheter Market Outlook, By Product (2022-2030) ($MN)
  • Table 25 North America Central Venous Catheter Market Outlook, By Tunneled Catheters (2022-2030) ($MN)
  • Table 26 North America Central Venous Catheter Market Outlook, By Non-Tunneled Catheters (2022-2030) ($MN)
  • Table 27 North America Central Venous Catheter Market Outlook, By Property (2022-2030) ($MN)
  • Table 28 North America Central Venous Catheter Market Outlook, By Antimicrobial Catheters (2022-2030) ($MN)
  • Table 29 North America Central Venous Catheter Market Outlook, By Non-Antimicrobial Catheters (2022-2030) ($MN)
  • Table 30 North America Central Venous Catheter Market Outlook, By Design (2022-2030) ($MN)
  • Table 31 North America Central Venous Catheter Market Outlook, By Single Lumen (2022-2030) ($MN)
  • Table 32 North America Central Venous Catheter Market Outlook, By Double Lumen (2022-2030) ($MN)
  • Table 33 North America Central Venous Catheter Market Outlook, By Multiple Lumen (2022-2030) ($MN)
  • Table 34 North America Central Venous Catheter Market Outlook, By Composition (2022-2030) ($MN)
  • Table 35 North America Central Venous Catheter Market Outlook, By Polyurethane (2022-2030) ($MN)
  • Table 36 North America Central Venous Catheter Market Outlook, By Teflon (2022-2030) ($MN)
  • Table 37 North America Central Venous Catheter Market Outlook, By Silicone Rubber (2022-2030) ($MN)
  • Table 38 North America Central Venous Catheter Market Outlook, By Other Compositions (2022-2030) ($MN)
  • Table 39 North America Central Venous Catheter Market Outlook, By End User (2022-2030) ($MN)
  • Table 40 North America Central Venous Catheter Market Outlook, By Hospitals (2022-2030) ($MN)
  • Table 41 North America Central Venous Catheter Market Outlook, By Ambulatory Surgical Centers (2022-2030) ($MN)
  • Table 42 North America Central Venous Catheter Market Outlook, By Specialized Clinics (2022-2030) ($MN)
  • Table 43 North America Central Venous Catheter Market Outlook, By Cancer Research Institutes (2022-2030) ($MN)
  • Table 44 North America Central Venous Catheter Market Outlook, By Other End Users (2022-2030) ($MN)
  • Table 45 Europe Central Venous Catheter Market Outlook, By Country (2022-2030) ($MN)
  • Table 46 Europe Central Venous Catheter Market Outlook, By Product (2022-2030) ($MN)
  • Table 47 Europe Central Venous Catheter Market Outlook, By Tunneled Catheters (2022-2030) ($MN)
  • Table 48 Europe Central Venous Catheter Market Outlook, By Non-Tunneled Catheters (2022-2030) ($MN)
  • Table 49 Europe Central Venous Catheter Market Outlook, By Property (2022-2030) ($MN)
  • Table 50 Europe Central Venous Catheter Market Outlook, By Antimicrobial Catheters (2022-2030) ($MN)
  • Table 51 Europe Central Venous Catheter Market Outlook, By Non-Antimicrobial Catheters (2022-2030) ($MN)
  • Table 52 Europe Central Venous Catheter Market Outlook, By Design (2022-2030) ($MN)
  • Table 53 Europe Central Venous Catheter Market Outlook, By Single Lumen (2022-2030) ($MN)
  • Table 54 Europe Central Venous Catheter Market Outlook, By Double Lumen (2022-2030) ($MN)
  • Table 55 Europe Central Venous Catheter Market Outlook, By Multiple Lumen (2022-2030) ($MN)
  • Table 56 Europe Central Venous Catheter Market Outlook, By Composition (2022-2030) ($MN)
  • Table 57 Europe Central Venous Catheter Market Outlook, By Polyurethane (2022-2030) ($MN)
  • Table 58 Europe Central Venous Catheter Market Outlook, By Teflon (2022-2030) ($MN)
  • Table 59 Europe Central Venous Catheter Market Outlook, By Silicone Rubber (2022-2030) ($MN)
  • Table 60 Europe Central Venous Catheter Market Outlook, By Other Compositions (2022-2030) ($MN)
  • Table 61 Europe Central Venous Catheter Market Outlook, By End User (2022-2030) ($MN)
  • Table 62 Europe Central Venous Catheter Market Outlook, By Hospitals (2022-2030) ($MN)
  • Table 63 Europe Central Venous Catheter Market Outlook, By Ambulatory Surgical Centers (2022-2030) ($MN)
  • Table 64 Europe Central Venous Catheter Market Outlook, By Specialized Clinics (2022-2030) ($MN)
  • Table 65 Europe Central Venous Catheter Market Outlook, By Cancer Research Institutes (2022-2030) ($MN)
  • Table 66 Europe Central Venous Catheter Market Outlook, By Other End Users (2022-2030) ($MN)
  • Table 67 Asia Pacific Central Venous Catheter Market Outlook, By Country (2022-2030) ($MN)
  • Table 68 Asia Pacific Central Venous Catheter Market Outlook, By Product (2022-2030) ($MN)
  • Table 69 Asia Pacific Central Venous Catheter Market Outlook, By Tunneled Catheters (2022-2030) ($MN)
  • Table 70 Asia Pacific Central Venous Catheter Market Outlook, By Non-Tunneled Catheters (2022-2030) ($MN)
  • Table 71 Asia Pacific Central Venous Catheter Market Outlook, By Property (2022-2030) ($MN)
  • Table 72 Asia Pacific Central Venous Catheter Market Outlook, By Antimicrobial Catheters (2022-2030) ($MN)
  • Table 73 Asia Pacific Central Venous Catheter Market Outlook, By Non-Antimicrobial Catheters (2022-2030) ($MN)
  • Table 74 Asia Pacific Central Venous Catheter Market Outlook, By Design (2022-2030) ($MN)
  • Table 75 Asia Pacific Central Venous Catheter Market Outlook, By Single Lumen (2022-2030) ($MN)
  • Table 76 Asia Pacific Central Venous Catheter Market Outlook, By Double Lumen (2022-2030) ($MN)
  • Table 77 Asia Pacific Central Venous Catheter Market Outlook, By Multiple Lumen (2022-2030) ($MN)
  • Table 78 Asia Pacific Central Venous Catheter Market Outlook, By Composition (2022-2030) ($MN)
  • Table 79 Asia Pacific Central Venous Catheter Market Outlook, By Polyurethane (2022-2030) ($MN)
  • Table 80 Asia Pacific Central Venous Catheter Market Outlook, By Teflon (2022-2030) ($MN)
  • Table 81 Asia Pacific Central Venous Catheter Market Outlook, By Silicone Rubber (2022-2030) ($MN)
  • Table 82 Asia Pacific Central Venous Catheter Market Outlook, By Other Compositions (2022-2030) ($MN)
  • Table 83 Asia Pacific Central Venous Catheter Market Outlook, By End User (2022-2030) ($MN)
  • Table 84 Asia Pacific Central Venous Catheter Market Outlook, By Hospitals (2022-2030) ($MN)
  • Table 85 Asia Pacific Central Venous Catheter Market Outlook, By Ambulatory Surgical Centers (2022-2030) ($MN)
  • Table 86 Asia Pacific Central Venous Catheter Market Outlook, By Specialized Clinics (2022-2030) ($MN)
  • Table 87 Asia Pacific Central Venous Catheter Market Outlook, By Cancer Research Institutes (2022-2030) ($MN)
  • Table 88 Asia Pacific Central Venous Catheter Market Outlook, By Other End Users (2022-2030) ($MN)
  • Table 89 South America Central Venous Catheter Market Outlook, By Country (2022-2030) ($MN)
  • Table 90 South America Central Venous Catheter Market Outlook, By Product (2022-2030) ($MN)
  • Table 91 South America Central Venous Catheter Market Outlook, By Tunneled Catheters (2022-2030) ($MN)
  • Table 92 South America Central Venous Catheter Market Outlook, By Non-Tunneled Catheters (2022-2030) ($MN)
  • Table 93 South America Central Venous Catheter Market Outlook, By Property (2022-2030) ($MN)
  • Table 94 South America Central Venous Catheter Market Outlook, By Antimicrobial Catheters (2022-2030) ($MN)
  • Table 95 South America Central Venous Catheter Market Outlook, By Non-Antimicrobial Catheters (2022-2030) ($MN)
  • Table 96 South America Central Venous Catheter Market Outlook, By Design (2022-2030) ($MN)
  • Table 97 South America Central Venous Catheter Market Outlook, By Single Lumen (2022-2030) ($MN)
  • Table 98 South America Central Venous Catheter Market Outlook, By Double Lumen (2022-2030) ($MN)
  • Table 99 South America Central Venous Catheter Market Outlook, By Multiple Lumen (2022-2030) ($MN)
  • Table 100 South America Central Venous Catheter Market Outlook, By Composition (2022-2030) ($MN)
  • Table 101 South America Central Venous Catheter Market Outlook, By Polyurethane (2022-2030) ($MN)
  • Table 102 South America Central Venous Catheter Market Outlook, By Teflon (2022-2030) ($MN)
  • Table 103 South America Central Venous Catheter Market Outlook, By Silicone Rubber (2022-2030) ($MN)
  • Table 104 South America Central Venous Catheter Market Outlook, By Other Compositions (2022-2030) ($MN)
  • Table 105 South America Central Venous Catheter Market Outlook, By End User (2022-2030) ($MN)
  • Table 106 South America Central Venous Catheter Market Outlook, By Hospitals (2022-2030) ($MN)
  • Table 107 South America Central Venous Catheter Market Outlook, By Ambulatory Surgical Centers (2022-2030) ($MN)
  • Table 108 South America Central Venous Catheter Market Outlook, By Specialized Clinics (2022-2030) ($MN)
  • Table 109 South America Central Venous Catheter Market Outlook, By Cancer Research Institutes (2022-2030) ($MN)
  • Table 110 South America Central Venous Catheter Market Outlook, By Other End Users (2022-2030) ($MN)
  • Table 111 Middle East & Africa Central Venous Catheter Market Outlook, By Country (2022-2030) ($MN)
  • Table 112 Middle East & Africa Central Venous Catheter Market Outlook, By Product (2022-2030) ($MN)
  • Table 113 Middle East & Africa Central Venous Catheter Market Outlook, By Tunneled Catheters (2022-2030) ($MN)
  • Table 114 Middle East & Africa Central Venous Catheter Market Outlook, By Non-Tunneled Catheters (2022-2030) ($MN)
  • Table 115 Middle East & Africa Central Venous Catheter Market Outlook, By Property (2022-2030) ($MN)
  • Table 116 Middle East & Africa Central Venous Catheter Market Outlook, By Antimicrobial Catheters (2022-2030) ($MN)
  • Table 117 Middle East & Africa Central Venous Catheter Market Outlook, By Non-Antimicrobial Catheters (2022-2030) ($MN)
  • Table 118 Middle East & Africa Central Venous Catheter Market Outlook, By Design (2022-2030) ($MN)
  • Table 119 Middle East & Africa Central Venous Catheter Market Outlook, By Single Lumen (2022-2030) ($MN)
  • Table 120 Middle East & Africa Central Venous Catheter Market Outlook, By Double Lumen (2022-2030) ($MN)
  • Table 121 Middle East & Africa Central Venous Catheter Market Outlook, By Multiple Lumen (2022-2030) ($MN)
  • Table 122 Middle East & Africa Central Venous Catheter Market Outlook, By Composition (2022-2030) ($MN)
  • Table 123 Middle East & Africa Central Venous Catheter Market Outlook, By Polyurethane (2022-2030) ($MN)
  • Table 124 Middle East & Africa Central Venous Catheter Market Outlook, By Teflon (2022-2030) ($MN)
  • Table 125 Middle East & Africa Central Venous Catheter Market Outlook, By Silicone Rubber (2022-2030) ($MN)
  • Table 126 Middle East & Africa Central Venous Catheter Market Outlook, By Other Compositions (2022-2030) ($MN)
  • Table 127 Middle East & Africa Central Venous Catheter Market Outlook, By End User (2022-2030) ($MN)
  • Table 128 Middle East & Africa Central Venous Catheter Market Outlook, By Hospitals (2022-2030) ($MN)
  • Table 129 Middle East & Africa Central Venous Catheter Market Outlook, By Ambulatory Surgical Centers (2022-2030) ($MN)
  • Table 130 Middle East & Africa Central Venous Catheter Market Outlook, By Specialized Clinics (2022-2030) ($MN)
  • Table 131 Middle East & Africa Central Venous Catheter Market Outlook, By Cancer Research Institutes (2022-2030) ($MN)
  • Table 132 Middle East & Africa Central Venous Catheter Market Outlook, By Other End Users (2022-2030) ($MN)